CEA, Pleural Fluid
Also known as: CEA, Thoracentesis Fluid, Carcinoembryonic Antigen, CEA, Chest Fluid
Use
Determination of CEA in pleural fluid is useful in the diagnosis/classification of malignant effusions of the lung. Values should be used in conjunction with cytological analysis, imaging studies, and clinical findings, and CEA levels should not be interpreted as absolute evidence of presence or absence of disease.
Special Instructions
Not provided.
Limitations
Values obtained from different assay methods cannot be used interchangeably. CEA levels, regardless of value, should not be interpreted as absolute evidence of presence or absence of disease.
Methodology
Immunoassay (CLIA)
Biomarkers
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
3 mL
Minimum Volume
2 mL
Container
sterile plastic leak‑proof container
Causes for Rejection
fluid sources other than pleural fluid
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 28 days |
| Frozen | 28 days |